SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000894579-13-000227
Filing Date
2013-11-21
Accepted
2013-11-21 13:49:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A cti13da112113.htm SC 13D/A 75107
  Complete submission text file 0000894579-13-000227.txt   76391
Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address
AUSTIN JOSIAH T (Filed by) CIK: 0000932267 (see all company filings)

Type: SC 13D/A

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81457 | Film No.: 131234966
SIC: 2836 Biological Products, (No Diagnostic Substances)